GDRX Stock Analysis: Buy, Sell, or Hold?
GDRX - GoodRx Holdings, Inc. Class A Common Stock
$2.27
-0.13 (-5.42%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Smart Money Accumulation
GDRX is down 11.3% this week, but smart money is accumulating calls. Top strike: $2.5 2026-04-17 with 1,840 OI. Call ratio: 62% View Scanner →
Strength: 6.9/10
Get Alerted When GDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called GDRX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GDRX is down 11.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GDRX is down 11.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.78
Based on 12.1% avg growth
INTRINSIC VALUE TODAY
$2.97
23.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GDRX is currently trading at $2.27, which is considered oversold relative to its 30-day fair value range of $2.50 to $2.84. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.5) compared to its historical average (6.3). Remarkably, the market is currently pricing in an annual earnings decline of 4.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, GDRX is in a strong downtrend. The price is currently testing key support at $2.24. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.56 (+90.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GDRX is in a strong downtrend. The price is currently testing key support at $2.24. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.56 (+90.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.50 -
$2.84
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding GDRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 90.0% below Wall St target ($4.56)
- WARNING: Recommendation downgraded due to -11.3% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.50 -
$2.84
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$2.24
Resistance Level
$2.75
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
5.55
Wall Street Target
$4.56
(+90.0%)
Revenue Growth (YoY)
0.4%
Earnings Growth (YoY)
-67.8%
Profit Margin
4.0%
Valuation Discount vs History
-4.2% cheaper
PE vs Historical
5.6 vs 6.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.2%
(market-implied from PE analysis)
1-Year Target
$2.30
(-4%)
2-Year Target
$2.20
(-8%)
3-Year Target
$2.11
(-12%)
3-Yr Target (if PE normalizes)
(PE: 6→6)
$2.39
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 20.1%)
$16.69
(+596%)
Base:
(SPY PE: 5.6, Growth: 20.1%)
$4.16
(+73%)
Bear:
(PE: 4.7, Growth: 20.1%)
$3.53
(+47%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Trailing PE: 29.25 | Current EPS (TTM): $0.08
Bull Case
$5.15
(+127%)
Analyst growth 100.0%, PE expands to 32.2
Base Case
$4.68
(+106%)
Market implied 100.0%, PE stable at 29.3
Bear Case
$1.59
(-30%)
Severe decline -20.0%, PE contracts to 24.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.6 to 6.3
Stabilization Target:
$2.72
(+13.5%)
PE Expansion Potential:
+13.5%
Last updated: January 31, 2026 4:30 AM ET
Data refreshes hourly during market hours. Next update: 5:30 AM
Data refreshes hourly during market hours. Next update: 5:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GDRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Equity Vii L.P. Spectrum
SELL
23771 shares
2025-10-15
Equity Vii L.P. Spectrum
SELL
16016 shares
2025-09-05
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$310 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$29 | 48 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 55 HOLD |
Advanced GDRX Option Strategies
Professional options setups generated by AI based on today's GDRX price and gamma walls.
